Cargando…

Adherence to Dihydroartemisinin-Piperaquine Treatment among Patients with Uncomplicated Malaria in Northern Ghana

Treatment adherence has been described as the process whereby patients take medications, follow diet, and effect other lifestyle changes that relate to agreed recommendations from healthcare providers. The determinants of such treatment adherence include patient, the health condition, therapy type,...

Descripción completa

Detalles Bibliográficos
Autores principales: Oduro, Abraham Rexford, Chatio, Samuel, Beeri, Paula, Anyorigiya, Thomas, Baiden, Rita, Adongo, Philip, Akweongo, Patricia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6463560/
https://www.ncbi.nlm.nih.gov/pubmed/31057628
http://dx.doi.org/10.1155/2019/5198010
_version_ 1783410774477111296
author Oduro, Abraham Rexford
Chatio, Samuel
Beeri, Paula
Anyorigiya, Thomas
Baiden, Rita
Adongo, Philip
Akweongo, Patricia
author_facet Oduro, Abraham Rexford
Chatio, Samuel
Beeri, Paula
Anyorigiya, Thomas
Baiden, Rita
Adongo, Philip
Akweongo, Patricia
author_sort Oduro, Abraham Rexford
collection PubMed
description Treatment adherence has been described as the process whereby patients take medications, follow diet, and effect other lifestyle changes that relate to agreed recommendations from healthcare providers. The determinants of such treatment adherence include patient, the health condition, therapy type, socioeconomic conditions, and the healthcare system. The study examined adherence in malaria patients treated with dihydroartemisinin-piperaquine in routine clinical care in northern Ghana. The study was conducted in Navrongo Health Research Centre in the Kassena-Nankana district of northern Ghana. Patients confirmed with uncomplicated malaria were prescribed dihydroartemisinin-piperaquine in blister packs to be taken daily for three days. Follow-up visits were made on days 3 and 28 after diagnosis to collect data on adherence, drug safety and therapeutic effectiveness. During follow-up visits, in-depth interviews were conducted and the blister packs directly observed for the number of tablets remaining. The in-depth interviews documented day-by-day account of doses taken, number of tablets taken during each dose, time of each dose, reasons for any leftover or missed dose, and whether or not there was vomiting. Treatment adherence was classified as definitely nonadherent, incomplete adherence, and completely adherent. A total of 405 patients were screened; 299 were positive by rapid diagnostic testing and 216 by microscopy. The average age was 12 years and females represented 54.0%. All participants completed day 3 follow-up but 12.7% had leftover pills. Treatment adherence was 50.9% (95% CI 44.1, 57.8), 36.1% (95% CI 29.7, 42.9), and 13.0% (95% CI 8.8, 18.2) for completely adherent, incomplete adherence, and definitely nonadherent, respectively. All completely adherent patients were free of parasitemia on day 28 of follow-up. A total of 49 adverse events related to malaria symptoms were documented. Effort to improve adherence should be individualized as it is dependent on a number of factors such as the patients' temperament, the disease, support at home, and complexity of treatment.
format Online
Article
Text
id pubmed-6463560
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Hindawi
record_format MEDLINE/PubMed
spelling pubmed-64635602019-05-05 Adherence to Dihydroartemisinin-Piperaquine Treatment among Patients with Uncomplicated Malaria in Northern Ghana Oduro, Abraham Rexford Chatio, Samuel Beeri, Paula Anyorigiya, Thomas Baiden, Rita Adongo, Philip Akweongo, Patricia J Trop Med Research Article Treatment adherence has been described as the process whereby patients take medications, follow diet, and effect other lifestyle changes that relate to agreed recommendations from healthcare providers. The determinants of such treatment adherence include patient, the health condition, therapy type, socioeconomic conditions, and the healthcare system. The study examined adherence in malaria patients treated with dihydroartemisinin-piperaquine in routine clinical care in northern Ghana. The study was conducted in Navrongo Health Research Centre in the Kassena-Nankana district of northern Ghana. Patients confirmed with uncomplicated malaria were prescribed dihydroartemisinin-piperaquine in blister packs to be taken daily for three days. Follow-up visits were made on days 3 and 28 after diagnosis to collect data on adherence, drug safety and therapeutic effectiveness. During follow-up visits, in-depth interviews were conducted and the blister packs directly observed for the number of tablets remaining. The in-depth interviews documented day-by-day account of doses taken, number of tablets taken during each dose, time of each dose, reasons for any leftover or missed dose, and whether or not there was vomiting. Treatment adherence was classified as definitely nonadherent, incomplete adherence, and completely adherent. A total of 405 patients were screened; 299 were positive by rapid diagnostic testing and 216 by microscopy. The average age was 12 years and females represented 54.0%. All participants completed day 3 follow-up but 12.7% had leftover pills. Treatment adherence was 50.9% (95% CI 44.1, 57.8), 36.1% (95% CI 29.7, 42.9), and 13.0% (95% CI 8.8, 18.2) for completely adherent, incomplete adherence, and definitely nonadherent, respectively. All completely adherent patients were free of parasitemia on day 28 of follow-up. A total of 49 adverse events related to malaria symptoms were documented. Effort to improve adherence should be individualized as it is dependent on a number of factors such as the patients' temperament, the disease, support at home, and complexity of treatment. Hindawi 2019-04-01 /pmc/articles/PMC6463560/ /pubmed/31057628 http://dx.doi.org/10.1155/2019/5198010 Text en Copyright © 2019 Abraham Rexford Oduro et al. https://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Article
Oduro, Abraham Rexford
Chatio, Samuel
Beeri, Paula
Anyorigiya, Thomas
Baiden, Rita
Adongo, Philip
Akweongo, Patricia
Adherence to Dihydroartemisinin-Piperaquine Treatment among Patients with Uncomplicated Malaria in Northern Ghana
title Adherence to Dihydroartemisinin-Piperaquine Treatment among Patients with Uncomplicated Malaria in Northern Ghana
title_full Adherence to Dihydroartemisinin-Piperaquine Treatment among Patients with Uncomplicated Malaria in Northern Ghana
title_fullStr Adherence to Dihydroartemisinin-Piperaquine Treatment among Patients with Uncomplicated Malaria in Northern Ghana
title_full_unstemmed Adherence to Dihydroartemisinin-Piperaquine Treatment among Patients with Uncomplicated Malaria in Northern Ghana
title_short Adherence to Dihydroartemisinin-Piperaquine Treatment among Patients with Uncomplicated Malaria in Northern Ghana
title_sort adherence to dihydroartemisinin-piperaquine treatment among patients with uncomplicated malaria in northern ghana
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6463560/
https://www.ncbi.nlm.nih.gov/pubmed/31057628
http://dx.doi.org/10.1155/2019/5198010
work_keys_str_mv AT oduroabrahamrexford adherencetodihydroartemisininpiperaquinetreatmentamongpatientswithuncomplicatedmalariainnorthernghana
AT chatiosamuel adherencetodihydroartemisininpiperaquinetreatmentamongpatientswithuncomplicatedmalariainnorthernghana
AT beeripaula adherencetodihydroartemisininpiperaquinetreatmentamongpatientswithuncomplicatedmalariainnorthernghana
AT anyorigiyathomas adherencetodihydroartemisininpiperaquinetreatmentamongpatientswithuncomplicatedmalariainnorthernghana
AT baidenrita adherencetodihydroartemisininpiperaquinetreatmentamongpatientswithuncomplicatedmalariainnorthernghana
AT adongophilip adherencetodihydroartemisininpiperaquinetreatmentamongpatientswithuncomplicatedmalariainnorthernghana
AT akweongopatricia adherencetodihydroartemisininpiperaquinetreatmentamongpatientswithuncomplicatedmalariainnorthernghana